Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Ford

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Multiple Sclerosis and Related Disorders|May 31, 2022
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)Ruth Dobson, Matthew Craner, Ed Waddingham, et al.
Therapeutic Advances in Neurological Disorders|February 17, 2022
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patientsKimberley Allen-Philbey, Stefania De Trane, Zhifeng Mao, et al.
BMJ Neurology Open|September 12, 2024
Brain reserve and physical disability in secondary progressive multiple sclerosisNevin John, Yingtong Li, Floriana De Angelis, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Multiple Sclerosis and Related Disorders|May 31, 2022
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)Ruth Dobson, Matthew Craner, Ed Waddingham, et al.
Therapeutic Advances in Neurological Disorders|February 17, 2022
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patientsKimberley Allen-Philbey, Stefania De Trane, Zhifeng Mao, et al.
BMJ Neurology Open|September 12, 2024
Brain reserve and physical disability in secondary progressive multiple sclerosisNevin John, Yingtong Li, Floriana De Angelis, et al.
Pageof 4